levamisole has been researched along with tamoxifen in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Bilter, GK; Dias, J; Huang, Z; Keon, BH; Lamerdin, J; MacDonald, ML; Michnick, SW; Minami, T; Owens, S; Shang, Z; Westwick, JK; Yu, H | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
Brincker, H; Christensen, JJ; Frederiksen, PL; Johansen, H; Laursen, F; Nybo-Rasmussen, A; Overgaard, M; Panduro, J; Sørensen, NE; van der Kooy, P | 1 |
Andersen, J; Andersen, KW; Birkler, NE; Ejlertsen, B; Kamby, C; Rose, C; Rytter, L; Zedeler, K | 1 |
Holden-Dye, L; Trim, N; Walker, RJ | 1 |
1 trial(s) available for levamisole and tamoxifen
Article | Year |
---|---|
Postmastectomy irradiation in high-risk breast cancer patients. Present status of the Danish Breast Cancer Cooperative Group trials.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Female; Fluorouracil; Humans; Levamisole; Mastectomy, Simple; Methotrexate; Random Allocation; Risk Factors; Tamoxifen | 1988 |
7 other study(ies) available for levamisole and tamoxifen
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Identifying off-target effects and hidden phenotypes of drugs in human cells.
Topics: Bacterial Proteins; Cell Line; Cell Proliferation; Cluster Analysis; Drug Design; Drug Evaluation, Preclinical; Genetics; Humans; Luminescent Proteins; Molecular Structure; Phenotype; Recombinant Fusion Proteins; Signal Transduction; Structure-Activity Relationship | 2006 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
Adjuvant systemic treatment and the pattern of recurrences in patients with breast cancer.
Topics: Antineoplastic Agents; Bone Neoplasms; Breast Neoplasms; Combined Modality Therapy; Female; Humans; Levamisole; Liver Neoplasms; Lung Neoplasms; Mastectomy; Middle Aged; Neoplasm Metastasis; Recurrence; Tamoxifen | 1988 |
The inhibitory action of tamoxifen on the contraction of Ascaris suum somatic muscle in response to acetylcholine.
Topics: Acetylcholine; Alkaloids; Animals; Ascaris suum; Benzophenanthridines; Electrophysiology; Levamisole; Muscle Contraction; Muscles; Phenanthridines; Tamoxifen | 1999 |